Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0001209191-23-004502

See Remarks sold 6,537 shares at an average $5.09 ($33,287)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Sinha Vikas See Remarks 2023-01-19 Sale −5,111 $5.08 $25,952 1,031,664 D: show line 1 in the form
Sinha Vikas See Remarks 2023-01-20 Sale −1,426 $5.14 $7,335 1,030,238 D: show line 2 in the form
Open-market sales · 6,537 sh · avg $5.09 · $33,287
Loading xslF345X03/doc4.xml…